A randomised, double-blind, placebo-controlled, multicentre clinical trial of AZD1656 in diabetic patients hospitalised with COVID-19: The ARCADIA Trial - implications for therapeutic immune modulation
- Resource Type
- Article
- Source
- In
eClinicalMedicine September 2022 51 - Subject
- Language
- ISSN
- 2589-5370